Ignite Creation Date:
2024-05-06 @ 8:15 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06315205
Status:
RECRUITING
Last Update Posted:
2024-03-19
First Post:
2024-03-11
Brief Title:
Evaluation of the Pharmacokinetics Safety and Tolerability of IM Letrozole LEBE in Healthy Post-menopausal Women
Sponsor:
Rovi Pharmaceuticals Laboratories
Organization:
Rovi Pharmaceuticals Laboratories
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-26
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-11
First Submit QC Date:
March 11 2024
Study First Post Date:
2024-03-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-18
Last Update Post Date:
2024-03-19
Last Update Post Date Type:
ACTUAL